What is Taro Pharmaceutical Industries Median PS Value?
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Taro Pharmaceutical Industries's Median PS Value or its related term are showing as below:
TARO'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.31 Med: 0.82 Max: 1.58
Current: 0.52
During the past 13 years, the highest Price to Median PS Value of Taro Pharmaceutical Industries was 1.58. The lowest was 0.31. And the median was 0.82.
TARO's Price-to-Median-PS-Value is ranked better than 78.4% of 500
companies
in the Drug Manufacturers industry
Industry Median: 0.8
vs TARO: 0.52
Taro Pharmaceutical Industries Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Taro Pharmaceutical Industries Median PS Value Chart
Competitive Comparison of Taro Pharmaceutical Industries's Median PS Value
For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taro Pharmaceutical Industries's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Taro Pharmaceutical Industries's Price-to-Median-PS-Value falls into.
Taro Pharmaceutical Industries Median PS Value Calculation
10-Year Median PS Ratio is 5.0849.
Taro Pharmaceutical Industries's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.252.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taro Pharmaceutical Industries (NYSE:TARO) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Taro Pharmaceutical Industries's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
42.40
/
82.64
=
0.51
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taro Pharmaceutical Industries Median PS Value Related Terms
Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TARO has been successfully added to your 